ArticleOncotarget2017

Isoliquiritigenin suppresses human T Lymphocyte activation via covalently binding cysteine 46 of IκB kinase.

Fenggen Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.